ESOKALLI Delay Performance Gel

Manufacturer
Guangzhou Yixin Cross-border E-commerce Co., Ltd.
Effective date
2025-11-03
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 01:41:54

Label at a glance#

ProductESOKALLI Delay Performance Gel
Active ingredientLIDOCAINE, ARGININE
Label structure11 sections

Indications and uses

Helps temporarily reduce sensitivity for better control. Supports local blood flow for enhanced firmness and endurance.

Dosage and administration

Apply a small amount (pea-sized) to the glans or desired area 5–10 minutes before activity. Allow to absorb completely before contact. Wash off after use.

Label contents#

Full prescribing information#

Active Ingredients (per 100 g):

COMPONENTS

Lidocaine 2.0% — Topical anesthetic (delays climax)
L-Arginine 0.1% — Nitric oxide enhancer (supports circulation)

Purpose:

OTC - PURPOSE SECTION

Male desensitizing and performance enhancement gel.

Uses:

INDICATIONS & USAGE SECTION

Helps temporarily reduce sensitivity for better control.
Supports local blood flow for enhanced firmness and endurance.

Warnings:

WARNINGS SECTION

For external use only.
Avoid contact with eyes or broken or irritated skin.
Do not use if allergic to Lidocaine or other local anesthetics.
Do not use if you have heart disease, have undergone heart stent placement, or are taking nitrate-based medications (such as nitroglycerin or isosorbide dinitrate). The vasodilating effect of L-Arginine may affect cardiovascular stability.
Stop use and consult a doctor if irritation, rash, or burning occurs.
Keep out of reach of children.

Do not use if you:

OTC - DO NOT USE SECTION

For external use only.
Avoid contact with eyes or broken or irritated skin.
Do not use if allergic to Lidocaine or other local anesthetics.
Do not use if you have heart disease, have undergone heart stent placement, or are taking nitrate-based medications (such as nitroglycerin or isosorbide dinitrate). The vasodilating effect of L-Arginine may affect cardiovascular stability.
Stop use and consult a doctor if irritation, rash, or burning occurs.
Keep out of reach of children.

Dosage and Administration

DOSAGE & ADMINISTRATION SECTION

Apply a small amount (pea-sized) to the glans or desired area 5–10 minutes before activity.
Allow to absorb completely before contact.
Wash off after use.

When using this product you may experience:

OTC - WHEN USING SECTION

headache, flushing, indigestion, nasal congestion, dizziness, muscle pain, back pain, nausea, rash, or visual disturbances

Stop use and ask a doctor if:

OTC - STOP USE SECTION

you experience chest pain, fainting, sudden vision or hearing loss
an erection lasts longer than 4 hours (priapism). This is a medical emergency.

Contraindications

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Not for use in pregnant or breastfeeding women
Not for use in children under 18 years

Inactive ingredients

INACTIVE INGREDIENT SECTION

Anhydrous Alcohol, Glycerin, Propylene Glycol, Carbomer, Purified Water, Potassium Hydroxide.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

0101020203030404

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
070fbed5-7088-434a-a7ce-f2a64d8d40acProduct name220260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80fProduct name520250819
860a93dc-4863-49cc-b284-6bbe8191bc48Product name420250214
eaba870a-6a9d-442e-8643-87b3f558a451Product name120250117
9b4cf230-fd05-41d5-98c6-5db9ecb27b86Product name120230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57Product name320210602
aed701d5-9c75-dfaf-7154-cde46179faeaProduct name920200313
fa8b5901-e681-426f-82fe-54f6d81ec698Product name420180619
332d03e4-aa24-4b11-841a-02bf41081920Product name120171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070Product name120171221
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
68ed98f8-24c2-44a0-944a-6d36e82ce25aProduct name120141222
1681bc73-b05f-12c3-1075-382ae39f449cProduct name120140508
1cd42bc2-a430-c72b-636d-991b235fbf80Product name120140508
49fa150c-f0de-cce7-3d9c-993ed81c5698Product name120140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ffProduct name120140508
9137811f-f279-8640-5aeb-99fa2145d64dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84778-103-01ESOKALLI Delay Performance Gel1.8 mL in 1 TUBEGEL1.84
84778-103-01ESOKALLI Delay Performance Gel1 in 1 BOXGEL14
84778-103-02ESOKALLI Delay Performance Gel1.8 mL in 1 TUBEGEL1.84
84778-103-02ESOKALLI Delay Performance Gel2 in 1 BOXGEL24
84778-103-03ESOKALLI Delay Performance Gel1.8 mL in 1 TUBEGEL1.84
84778-103-03ESOKALLI Delay Performance Gel3 in 1 BOXGEL34
84778-103-04ESOKALLI Delay Performance Gel1.8 mL in 1 TUBEGEL1.84
84778-103-04ESOKALLI Delay Performance Gel4 in 1 BOXGEL44

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84778-10384778-103-01, 84778-103-02, 84778-103-03, 84778-103-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
42b2f99b-7bdf-cc56-e063-6294a90a27de41f89c38-32c2-f2fa-e063-6294a90ad6bd2025-11-03WarningsExact identifier
spl id: 42b2f99b-7bdf-cc56-e063-6294a90a27de
spl set id: 41f89c38-32c2-f2fa-e063-6294a90ad6bd

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.